Back to Search Start Over

Dyskerin Downregulation Can Induce ER Stress and Promote Autophagy via AKT-mTOR Signaling Deregulation.

Authors :
Maiello, Daniela
Varone, Marianna
Vicidomini, Rosario
Belli, Valentina
De Rosa, Marina
Dama, Paola
Furia, Maria
Turano, Mimmo
Source :
Biomedicines; May2022, Vol. 10 Issue 5, p1092, 21p
Publication Year :
2022

Abstract

Dyskerin is an evolutionarily conserved nucleolar protein implicated in a wide range of fundamental biological roles, including telomere maintenance and ribosome biogenesis. Germline mutations of DKC1, the human gene encoding dyskerin, cause the hereditary disorders known as X-linked dyskeratosis congenita (X-DC). Moreover, dyskerin is upregulated in several cancers. Due to the pleiotropic functions of dyskerin, the X-DC clinical features overlap with those of both telomeropathies and ribosomopathies. In this paper, we evaluate the telomerase-independent effects of dyskerin depletion on cellular physiology by using inducible DCK1 knockdown. This system allows the downregulation of DKC1 expression within a short timeframe. We report that, in these cellular systems, dyskerin depletion induces the accumulation of unfolded/misfolded proteins in the endoplasmic reticulum, which in turn induces the activation of the PERK branch of the unfolded protein response. We also demonstrate that the PERK-eIF2a-ATF4-CHOP signaling pathway, activated by dyskerin downregulation, triggers a functional autophagic flux through the inhibition of the PI3K/AKT/mTOR pathway. By revealing a novel unpredicted connection between the loss of dyskerin, autophagy and UPR, our results establish a firm link between the lowering of dyskerin levels and the activation of the ER stress response, that plays a key role in the pathogenesis of several diseases. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
22279059
Volume :
10
Issue :
5
Database :
Complementary Index
Journal :
Biomedicines
Publication Type :
Academic Journal
Accession number :
157131100
Full Text :
https://doi.org/10.3390/biomedicines10051092